APOE and atherosclerosis: Experimental studies, in which TGF-ß1 effects have been inhibited in blood vessels of atherosclerosis-prone ApoE (apolipoprotein E) knock-out mice by application of specific antibodies [6] or of recombinant soluble type II receptor [7] resulted in exacerbation of atherosclerosis.